IP Library Granted Patent US 9,937,125
Granted Patent B2
US 9,937,125 · App. 15/089,973 · Granted Apr 10, 2018

Intradialytic parenteral nutrition compositions

Inventor: Eileen Moore (Parma, OH)
Assignee: Pentec Health, Inc.
A61K9/08A23L33/40A61K31/195A61K31/198A61K31/20A61K31/401A61K31/405A61K31/7004A61K45/06A23V2002/00A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,937,125
App. No.
15/089,973
Granted
Apr 10, 2018
Kind
B2
Abstract

The invention provides intradialytic parenteral nutrition (IDPN) solutions with low carbohydrate for the treatment of malnutrition in dialysis patients. The IDPN solutions of the invention are particularly advantageous for the treatment of malnutrition in patients who are diabetic or suffer from other glucose management related pathologies or patients who require strict fluid management.

Claims (10)

1. A sterile aqueous intradialytic parenteral nutrition (IDPN) solution, comprising 0.05 to 0.07 g/mL of dextrose and 0.12 to 0.18 g/mL of amino acids, wherein the solution is lipid-free and the dextrose and the amino acids are dissolved in the same aqueous solution.

2. The sterile aqueous IDPN solution of claim 1 , wherein the solution comprises 0.055 to 0.065 g/mL of dextrose and 0.12 to 0.18 g/mL of amino acids.

3. The sterile aqueous IDPN solution of claim 1 , wherein the solution comprises 0.05 to 0.07 g/mL of dextrose and 0.15 to 0.17 g/mL of amino acids.

4. The sterile aqueous IDPN solution of claim 1 , wherein the solution comprises 0.055 to 0.065 g/mL of dextrose and 0.15 to 0.17 g/mL of amino acids.

5. The sterile aqueous IDPN solution of claim 1 , wherein the solution is free of vitamins.

6. The sterile aqueous IDPN solution of claim 1 , wherein the solution is free of minerals.

7. The sterile aqueous IDPN solution of claim 1 , wherein the amino acids include 17 of the standard amino acids.

8. The sterile aqueous IDPN solution of claim 1 , wherein the solution has a volume of 100 mL to 2 L.

9. The sterile aqueous IDPN solution of claim 1 , wherein the solution has a volume of 350 mL to 635 L.

10. The sterile aqueous IDPN solution of claim 1 , wherein the solution is packaged in a sterile container.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2024
From: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
To: PENTEC HEALTH, INC.
Reel/Frame 066941/0966 →
SECURITY INTEREST Recorded Mar 28, 2024
From: PENTEC HEALTH, INC.
To: CERBERUS BUSINESS FINANCE AGENCY, LLC
Reel/Frame 066930/0431 →
SECURITY INTEREST Recorded Oct 12, 2021
From: PENTEC HEALTH, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 057764/0908 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2021
From: CRESTLINE DIRECT FINANCE L.P.
To: PENTEC HEALTH, INC.
Reel/Frame 057752/0952 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 16, 2020
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: PENTEC HEALTH, INC.
Reel/Frame 054437/0511 →
SECURITY INTEREST Recorded Nov 13, 2020
From: PENTEC HEALTH, INC.
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 054357/0071 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 18, 2017
From: PENTEC HEALTH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 041389/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2017
From: MOORE, EILEEN
To: PENTEC HEALTH, INC.
Reel/Frame 040823/0469 →
Continuity (4)
Continuation 12498773 · Jul 7, 2009
Provisional Application 61078636 · Jul 7, 2008
Provisional Application 61080567 · Jul 14, 2008
Related Publication 20160235103A1 · Aug 18, 2016